dx 9065a has been researched along with Disease Models, Animal in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ono, T | 1 |
Alexander, J; Becker, RC; Dyke, CK; Harrington, RA | 1 |
Furugohri, T; Honda, Y; Isobe, K; Matsumoto, C; Muramatsu, S; Shiozaki, Y; Sugiyama, N | 1 |
Aoshima, K; Asakura, H; Ikeda, T; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M | 1 |
Kambayashi, J; Kawasaki, T; Kim, DI; Sakon, M; Shibuya, T | 1 |
Hara, T; Kunitada, S; Morishima, Y; Tanabe, K; Terada, Y | 1 |
Chi, L; Gallagher, KP; Kramer, JB; Rapundalo, ST; Rogers, KL | 1 |
Fareed, J; Kaiser, B; Kunitada, S; Paintz, M; Scholz, O | 1 |
Abendschein, DR; Baum, PK; Eisenberg, PR; Light, DR; Martin, DJ; Post, J; Rumennik, G; Sullivan, ME; Vergona, R | 1 |
2 review(s) available for dx 9065a and Disease Models, Animal
Article | Year |
---|---|
[Roles of coagulation pathway and factor Xa in chronic kidney disease (CKD)].
Topics: Animals; Blood Coagulation; Disease Models, Animal; Extracellular Matrix; Factor V; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Humans; Mice; Molecular Targeted Therapy; Naphthalenes; Polysaccharides; Propionates; Proteinuria; Rats; Receptor, PAR-2; Renal Insufficiency, Chronic; Signal Transduction | 2012 |
Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease.
Topics: Animals; Anticoagulants; Area Under Curve; Blood Coagulation; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Humans; International Normalized Ratio; Mice; Models, Biological; Models, Chemical; Naphthalenes; Pilot Projects; Platelet Aggregation Inhibitors; Propionates; Rats; Thrombin; Thromboplastin; Thrombosis; Time Factors | 2004 |
7 other study(ies) available for dx 9065a and Disease Models, Animal
Article | Year |
---|---|
Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models.
Topics: Animals; Azetidines; Benzylamines; Blood Coagulation; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Glycine; Male; Naphthalenes; Propionates; Rats; Rats, Wistar; Thrombin; Thromboplastin; Thrombosis | 2005 |
Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Disease Models, Animal; Disseminated Intravascular Coagulation; Factor X; Factor Xa Inhibitors; Male; Naphthalenes; Propionates; Rats; Rats, Wistar; Thromboplastin | 1996 |
In vivo evaluation of DX-9065a, a synthetic factor Xa inhibitor, in experimental vein graft.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Blood Vessel Prosthesis; Disease Models, Animal; Factor Xa Inhibitors; Graft Occlusion, Vascular; Heparin; Male; Microscopy, Electron, Scanning; Naphthalenes; Pipecolic Acids; Propionates; Rabbits; Sulfonamides; Thrombosis | 1996 |
Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants.
Topics: Animals; Anticoagulants; Antithrombin III; Arginine; Bleeding Time; Blood Coagulation; Disease Models, Animal; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Male; Naphthalenes; Peptide Hydrolases; Pipecolic Acids; Propionates; Rats; Rats, Wistar; Sulfonamides; Thrombin; Thrombosis | 1997 |
Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis.
Topics: Administration, Oral; Animals; Anticoagulants; Disease Models, Animal; Factor Xa Inhibitors; Hemostasis; Injections, Intravenous; Injections, Subcutaneous; Male; Naphthalenes; Platelet Aggregation Inhibitors; Propionates; Rabbits; Serine Proteinase Inhibitors; Venous Thrombosis | 1999 |
A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in rats.
Topics: Animals; Anticoagulants; Arteriosclerosis; Carotid Artery Injuries; Carotid Artery, Common; Cell Division; Disease Models, Animal; Factor Xa Inhibitors; Female; Male; Muscle, Smooth, Vascular; Naphthalenes; Propionates; Rats; Rats, Wistar; Recurrence | 2000 |
Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits.
Topics: Amidines; Animals; Anticoagulants; Antithrombin III; Arthropod Proteins; Coronary Thrombosis; Disease Models, Animal; Female; Intercellular Signaling Peptides and Proteins; Male; Naphthalenes; Peptides; Propionates; Pyridines; Rabbits; Species Specificity; Venous Thrombosis | 2000 |